Daiichi Sankyo Denies Report That It's Selling Over-the-Counter Drug Unit

On Thursday, Nikkei Business reported that Japan’s Daiichi Sankyo was in negotiations with several companies to sell its over-the-counter drug unit. The final price, Nikkei Business suggested, would hit around $900 million.